Christina Reith - Concepedia

Author

Christina Reith

Also Known As

A Reisler, C Reith, C. Reith, Christina A. Reith, Christina Reith, L E Holland, Lisa Blackwell, Reith, CA, S. Wilkinson, Simes, John

Publications

15.4K

Citations

H-Index

Concepts

All Affiliations

University of Oxford University College London Menzies School of Health Research University of Otago Medical Research Council

About

Christina Reith is an author at University of Oxford specializing in medicine, diabetes, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	7	3.9K
2	Diabetes	2	3	411
3	Health Sciences	1	1	125
4	Law	1	1	125
5	Health Law	1	1	125

Christina Reith

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Colin Baigent, Martin Landray, Christina Reith, The Lancet Cardiovascular DiseaseMedicineAntihypertensive TherapyHyperlipidemiaLdl Cholesterol	2011	2.4K
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Effects of Lowering LDL Cholesterol on Progression of Kidney Disease Richard Haynes, David Lewis, Jonathan Emberson, Journal of the American Society of Nephrology HypertensionHyperlipidemiaKidney DiseaseMetabolic SyndromeRenal Function	2014	172
Randomized Clinical Trials — Removing Unnecessary Obstacles Christina Reith, Martin Landray, P.J. Devereaux, New England Journal of Medicine Health PolicyClinical Trial ManagementClinical EndpointInformed ConsentClinical Trials	2013	125
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, BMC Nephrology	2015	117
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP) Natalie Staplin, Richard Haynes, William G. Herrington, American Journal of Kidney Diseases	2016	81
Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP) Richard Haynes, Natalie Staplin, Jonathan Emberson, American Journal of Kidney Diseases	2014	78

Page 1